Selected research
Market Structure
Global Rheolytic Thrombectomy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Rheolytic Thrombectomy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Rheolytic Thrombectomy include Abbott Laboratories, Koninklijke Philips N.V., Terumo Corporation, Boston Scientific Group, Medtronic plc, AngioDynamics, Penumbra Inc., Stryker Corporation and Teleflex Incorporated, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Rheolytic Thrombectomy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Rheolytic Thrombectomy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Rheolytic Thrombectomy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Rheolytic Thrombectomy market size, projected growth trends, production technologies, key applications, and end-use industries.
Rheolytic Thrombectomy Segment by Company
Abbott Laboratories
Koninklijke Philips N.V.
Terumo Corporation
Boston Scientific Group
Medtronic plc
AngioDynamics
Penumbra Inc.
Stryker Corporation
Teleflex Incorporated
Johnson and Johnson
Rheolytic Thrombectomy Segment by Type
Automated Devices
Manual Devices
Rheolytic Thrombectomy Segment by Application
Peripheral Diseases
Coronary Disease
Neural Diseases
Rheolytic Thrombectomy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheolytic Thrombectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rheolytic Thrombectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheolytic Thrombectomy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Rheolytic Thrombectomy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rheolytic Thrombectomy industry.
Chapter 3: Detailed analysis of Rheolytic Thrombectomy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheolytic Thrombectomyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Devices
- Manual Devices
Applications
- Peripheral Diseases
- Coronary Disease
- Neural Diseases
Companies covered
- Abbott Laboratories
- Koninklijke Philips N.V.
- Terumo Corporation
- Boston Scientific Group
- Medtronic plc
- AngioDynamics
- Penumbra Inc.
- Stryker Corporation
- Teleflex Incorporated
- Johnson and Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Rheolytic Thrombectomy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Automated Devices
- 1.2.3 Manual Devices
- 1.3 Market Analysis by Application
- 1.3.1 Global Rheolytic Thrombectomy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Peripheral Diseases
- 1.3.3 Coronary Disease
- 1.3.4 Neural Diseases
- 1.4 Global Market Growth Prospects
- 1.5 Global Rheolytic Thrombectomy Growth Trends by Region
- 1.5.1 Global Rheolytic Thrombectomy Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Rheolytic Thrombectomy Market Size by Region (2021-2026)
- 1.5.3 Rheolytic Thrombectomy Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Rheolytic Thrombectomy Market Dynamics
- 2.1 Rheolytic Thrombectomy Industry Trends
- 2.2 Rheolytic Thrombectomy Industry Drivers
- 2.3 Rheolytic Thrombectomy Industry Opportunities and Challenges
- 2.4 Rheolytic Thrombectomy Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Rheolytic Thrombectomy Revenue by Company (2021-2026)
- 3.2 Global Rheolytic Thrombectomy Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Rheolytic Thrombectomy Key Company Head office and Area Served
- 3.4 Global Rheolytic Thrombectomy Company, Product Type & Application
- 3.5 Global Rheolytic Thrombectomy Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Rheolytic Thrombectomy Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Rheolytic Thrombectomy Players Market Share by Revenue in 2025
- 3.6.3 2025 Rheolytic Thrombectomy Tier 1, Tier 2, and Tier 3
4 Rheolytic Thrombectomy Market by Type
- 4.1 Global Rheolytic Thrombectomy Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Rheolytic Thrombectomy Market Size by Type (2021-2032)
- 4.3 Global Rheolytic Thrombectomy Market Size Share by Type (2021-2032)
5 Rheolytic Thrombectomy Market by Application
- 5.1 Global Rheolytic Thrombectomy Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Rheolytic Thrombectomy Market Size by Application (2021-2032)
- 5.3 Global Rheolytic Thrombectomy Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abbott Laboratories
- 6.1.1 Abbott Laboratories Company Information
- 6.1.2 Abbott Laboratories Business Overview
- 6.1.3 Abbott Laboratories Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Abbott Laboratories Rheolytic Thrombectomy Product Portfolio
- 6.1.5 Abbott Laboratories Recent Developments
- 6.2 Koninklijke Philips N.V.
- 6.2.1 Koninklijke Philips N.V. Company Information
- 6.2.2 Koninklijke Philips N.V. Business Overview
- 6.2.3 Koninklijke Philips N.V. Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Koninklijke Philips N.V. Rheolytic Thrombectomy Product Portfolio
- 6.2.5 Koninklijke Philips N.V. Recent Developments
- 6.3 Terumo Corporation
- 6.3.1 Terumo Corporation Company Information
- 6.3.2 Terumo Corporation Business Overview
- 6.3.3 Terumo Corporation Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Terumo Corporation Rheolytic Thrombectomy Product Portfolio
- 6.3.5 Terumo Corporation Recent Developments
- 6.4 Boston Scientific Group
- 6.4.1 Boston Scientific Group Company Information
- 6.4.2 Boston Scientific Group Business Overview
- 6.4.3 Boston Scientific Group Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Boston Scientific Group Rheolytic Thrombectomy Product Portfolio
- 6.4.5 Boston Scientific Group Recent Developments
- 6.5 Medtronic plc
- 6.5.1 Medtronic plc Company Information
- 6.5.2 Medtronic plc Business Overview
- 6.5.3 Medtronic plc Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Medtronic plc Rheolytic Thrombectomy Product Portfolio
- 6.5.5 Medtronic plc Recent Developments
- 6.6 AngioDynamics
- 6.6.1 AngioDynamics Company Information
- 6.6.2 AngioDynamics Business Overview
- 6.6.3 AngioDynamics Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 AngioDynamics Rheolytic Thrombectomy Product Portfolio
- 6.6.5 AngioDynamics Recent Developments
- 6.7 Penumbra Inc.
- 6.7.1 Penumbra Inc. Company Information
- 6.7.2 Penumbra Inc. Business Overview
- 6.7.3 Penumbra Inc. Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Penumbra Inc. Rheolytic Thrombectomy Product Portfolio
- 6.7.5 Penumbra Inc. Recent Developments
- 6.8 Stryker Corporation
- 6.8.1 Stryker Corporation Company Information
- 6.8.2 Stryker Corporation Business Overview
- 6.8.3 Stryker Corporation Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Stryker Corporation Rheolytic Thrombectomy Product Portfolio
- 6.8.5 Stryker Corporation Recent Developments
- 6.9 Teleflex Incorporated
- 6.9.1 Teleflex Incorporated Company Information
- 6.9.2 Teleflex Incorporated Business Overview
- 6.9.3 Teleflex Incorporated Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Teleflex Incorporated Rheolytic Thrombectomy Product Portfolio
- 6.9.5 Teleflex Incorporated Recent Developments
- 6.10 Johnson and Johnson
- 6.10.1 Johnson and Johnson Company Information
- 6.10.2 Johnson and Johnson Business Overview
- 6.10.3 Johnson and Johnson Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Johnson and Johnson Rheolytic Thrombectomy Product Portfolio
- 6.10.5 Johnson and Johnson Recent Developments
7 North America
- 7.1 North America Rheolytic Thrombectomy Market Size (2021-2032)
- 7.2 North America Rheolytic Thrombectomy Market Size by Type
- 7.2.1 North America Rheolytic Thrombectomy Market Size by Type (2021-2026)
- 7.2.2 North America Rheolytic Thrombectomy Market Size by Type (2027-2032)
- 7.2.3 North America Rheolytic Thrombectomy Market Share by Type (2021-2032)
- 7.3 North America Rheolytic Thrombectomy Market Size by Application
- 7.3.1 North America Rheolytic Thrombectomy Market Size by Application (2021-2026)
- 7.3.2 North America Rheolytic Thrombectomy Market Size by Application (2027-2032)
- 7.3.3 North America Rheolytic Thrombectomy Market Share by Application (2021-2032)
- 7.4 North America Rheolytic Thrombectomy Market Size by Country
- 7.4.1 North America Rheolytic Thrombectomy Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 7.4.3 North America Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 7.4.4 North America Rheolytic Thrombectomy Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Rheolytic Thrombectomy Market Size (2021-2032)
- 8.2 Europe Rheolytic Thrombectomy Market Size by Type
- 8.2.1 Europe Rheolytic Thrombectomy Market Size by Type (2021-2026)
- 8.2.2 Europe Rheolytic Thrombectomy Market Size by Type (2027-2032)
- 8.2.3 Europe Rheolytic Thrombectomy Market Share by Type (2021-2032)
- 8.3 Europe Rheolytic Thrombectomy Market Size by Application
- 8.3.1 Europe Rheolytic Thrombectomy Market Size by Application (2021-2026)
- 8.3.2 Europe Rheolytic Thrombectomy Market Size by Application (2027-2032)
- 8.3.3 Europe Rheolytic Thrombectomy Market Share by Application (2021-2032)
- 8.4 Europe Rheolytic Thrombectomy Market Size by Country
- 8.4.1 Europe Rheolytic Thrombectomy Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 8.4.3 Europe Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 8.4.4 Europe Rheolytic Thrombectomy Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Rheolytic Thrombectomy Market Size (2021-2032)
- 9.2 China Rheolytic Thrombectomy Market Size by Type
- 9.2.1 China Rheolytic Thrombectomy Market Size by Type (2021-2026)
- 9.2.2 China Rheolytic Thrombectomy Market Size by Type (2027-2032)
- 9.2.3 China Rheolytic Thrombectomy Market Share by Type (2021-2032)
- 9.3 China Rheolytic Thrombectomy Market Size by Application
- 9.3.1 China Rheolytic Thrombectomy Market Size by Application (2021-2026)
- 9.3.2 China Rheolytic Thrombectomy Market Size by Application (2027-2032)
- 9.3.3 China Rheolytic Thrombectomy Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Rheolytic Thrombectomy Market Size (2021-2032)
- 10.2 Asia Rheolytic Thrombectomy Market Size by Type
- 10.2.1 Asia Rheolytic Thrombectomy Market Size by Type (2021-2026)
- 10.2.2 Asia Rheolytic Thrombectomy Market Size by Type (2027-2032)
- 10.2.3 Asia Rheolytic Thrombectomy Market Share by Type (2021-2032)
- 10.3 Asia Rheolytic Thrombectomy Market Size by Application
- 10.3.1 Asia Rheolytic Thrombectomy Market Size by Application (2021-2026)
- 10.3.2 Asia Rheolytic Thrombectomy Market Size by Application (2027-2032)
- 10.3.3 Asia Rheolytic Thrombectomy Market Share by Application (2021-2032)
- 10.4 Asia Rheolytic Thrombectomy Market Size by Country
- 10.4.1 Asia Rheolytic Thrombectomy Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 10.4.3 Asia Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 10.4.4 Asia Rheolytic Thrombectomy Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Rheolytic Thrombectomy Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Type
- 11.2.1 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Rheolytic Thrombectomy Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Application
- 11.3.1 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Rheolytic Thrombectomy Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Country
- 11.4.1 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Rheolytic Thrombectomy Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst